As of 2026-09-16, the Relative Valuation of Clearpoint Neuro Inc (CLPT) is (34.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.46 USD, the upside of Clearpoint Neuro Inc based on Relative Valuation is -353.1%.
The range of the Relative Valuation is (33.51) - (34.46) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 43.8x | 39.1x |
| Forward P/E multiples | 26.3x - 35.6x | 31.2x |
| Fair Price | (33.51) - (34.46) | (34.07) |
| Upside | -349.0% - -356.1% | -353.1% |
| Date | P/E |
| 2026-09-14 | -13.89 |
| 2026-09-11 | -14.16 |
| 2026-09-10 | -13.91 |
| 2026-09-09 | -14.32 |
| 2026-09-08 | -14.50 |
| 2026-09-04 | -14.40 |
| 2026-09-03 | -14.50 |
| 2026-09-02 | -14.76 |
| 2026-09-01 | -15.37 |
| 2026-08-31 | -15.62 |
| 2026-08-28 | -16.04 |
| 2026-08-27 | -16.45 |
| 2026-08-26 | -16.89 |
| 2026-08-25 | -17.50 |
| 2026-08-24 | -15.65 |
| 2026-08-21 | -15.88 |
| 2026-08-20 | -15.67 |
| 2026-08-19 | -16.47 |
| 2026-08-18 | -15.66 |
| 2026-08-17 | -15.99 |
| 2026-08-14 | -15.83 |
| 2026-08-13 | -15.91 |
| 2026-08-12 | -15.66 |
| 2026-08-11 | -15.37 |
| 2026-08-10 | -15.03 |
| 2026-08-07 | -14.66 |
| 2026-08-06 | -13.82 |
| 2026-08-05 | -13.58 |
| 2026-08-04 | -13.28 |
| 2026-08-03 | -15.87 |
| 2026-07-31 | -15.41 |
| 2026-07-30 | -15.04 |
| 2026-07-29 | -14.59 |
| 2026-07-28 | -14.99 |
| 2026-07-27 | -15.06 |
| 2026-07-24 | -14.57 |
| 2026-07-23 | -14.95 |
| 2026-07-22 | -15.51 |
| 2026-07-21 | -15.90 |
| 2026-07-20 | -15.53 |
| 2026-07-17 | -15.63 |
| 2026-07-16 | -15.54 |
| 2026-07-15 | -16.17 |
| 2026-07-14 | -16.47 |
| 2026-07-13 | -17.03 |
| 2026-07-10 | -18.06 |
| 2026-07-09 | -18.45 |
| 2026-07-08 | -17.84 |
| 2026-07-07 | -18.04 |
| 2026-07-06 | -18.57 |